The largest database of trusted experimental protocols

Gas chromatographic mass spectrometry

Manufactured by Thermo Fisher Scientific
Sourced in United States

Gas chromatographic mass spectrometry (GC-MS) is an analytical technique that combines gas chromatography and mass spectrometry to identify and quantify chemical compounds in a sample. The gas chromatograph separates the sample components, while the mass spectrometer detects and measures the molecular weight of each component.

Automatically generated - may contain errors

2 protocols using gas chromatographic mass spectrometry

1

Measuring Plasma Glucose Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were placed on ice, centrifuged at 4°C, separated, and stored at −20°C until assayed. Glucose concentrations were measured using a glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH, USA). Plasma insulin was measured using a chemiluminescence assay (Access Assay; Beckman Coulter, Chaska, MN, USA). Plasma glucagon and C-peptide were measured by Radio-Immunoassay (EMD Millipore, Billerica, MA, USA). Plasma [6,6-2H2] glucose and [1-13C] glucose enrichments were measured using gas chromatographic mass spectrometry (Thermoquest, San Jose, CA, USA) to simultaneously monitor the C-1 and C-2 and C-3 to C-6 fragments, as described by Beylot et al.23 (link) In addition, [6-3H] glucose specific activity was measured by liquid scintillation counting following deproteinization and passage over anion and cation exchange columns.22 (link)
+ Open protocol
+ Expand
2

Measurement of Glucose Metabolism Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were placed on ice, centrifuged at 4°C, separated, and stored at −20°C until assayed. Glucose concentrations were measured using a glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH). Plasma insulin was measured using a chemiluminescence assay (Access Assay; Beckman, Chaska, MN). Plasma glucagon and C-peptide were measured by Radio-Immunoassay (EMD Millipore, Billerica, MA). Collection tubes for GLP-1 had 100 μM of DPP-4 inhibitor added. Total GLP-1 concentrations were measured using a C-terminal assay (EMD Millipore, Billerica, MA). Plasma [6,6-2H2] glucose and [1-13C] glucose enrichments were measured using gas chromatographic mass spectrometry (Thermoquest, San Jose, CA) to simultaneously monitor the C-1 and C-2 and C-3 to C-6 fragments, as described previously [19 (link)]. In addition, [6-3H] glucose specific activity was measured by liquid scintillation counting following deproteinization and passage over anion and cation exchange columns [18 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!